HP
EXAS

HealthInvest Partners’s Exact Sciences EXAS Stock Holding History

HealthInvest Partners’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,120
Closed -$1.11M – 42
2024
Q1 		$1.11M Buy
16,120
+3,963
+33% +$251K 0.68% 34
2023
Q4 		$899K Buy
+12,157
New +$797K 0.7% 30
2022
Q4 		$13.3K Buy
+268
New +$10.9K 0.03% 36

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

HealthInvest Partners's EXAS Position: Q2 2024 in Review

HealthInvest Partners sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 16,120 shares — an estimated $1.11M sold.

HealthInvest Partners first reported a position in EXAS in Q4 2022 and held it in 3 quarters. The position peaked at $1.11M in Q1 2024. 544 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • HealthInvest Partners reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • HealthInvest Partners sold 16,120 Exact Sciences shares in Q2 2024, an estimated $1.11M.
  • HealthInvest Partners first reported a position in Exact Sciences in Q4 2022 and held it in 3 quarters.
  • HealthInvest Partners's Exact Sciences position peaked at $1.11M in Q1 2024.
  • 544 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on HealthInvest Partners's 13F filing for Q2 2024, filed 14 Aug 2024.